
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement
Maximilian Brinkhaus, Erwin Pannecoucke, Elvera J. van der Kooi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Maximilian Brinkhaus, Erwin Pannecoucke, Elvera J. van der Kooi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Showing 23 citing articles:
Multifunctional nanoparticle-mediated combining therapy for human diseases
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 112
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 112
Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy
Falk Nimmerjahn, Gestur Vidarsson, Mark S. Cragg
Nature Immunology (2023) Vol. 24, Iss. 8, pp. 1244-1255
Closed Access | Times Cited: 48
Falk Nimmerjahn, Gestur Vidarsson, Mark S. Cragg
Nature Immunology (2023) Vol. 24, Iss. 8, pp. 1244-1255
Closed Access | Times Cited: 48
Impact of structural modifications of IgG antibodies on effector functions
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 35
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 35
Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties
Nilufer P. Seth, Rui Xu, Matthew DuPrie, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Nilufer P. Seth, Rui Xu, Matthew DuPrie, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Effects of efgartigimod treatment on humoral and cellular immune responses: analysis of T-cell-dependent antibody response in cynomolgus monkeys
Ornella Binazon, Mario Cocco, Daniel Thwaites, et al.
Journal of Immunotoxicology (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Ornella Binazon, Mario Cocco, Daniel Thwaites, et al.
Journal of Immunotoxicology (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies
Arman Izadi, Yasaman Karami, Eleni Bratanis, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Arman Izadi, Yasaman Karami, Eleni Bratanis, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies
Roxane Biersteker, Øjvind Larsen, Manfred Wuhrer, et al.
Seminars in Immunology (2025) Vol. 78, pp. 101946-101946
Open Access
Roxane Biersteker, Øjvind Larsen, Manfred Wuhrer, et al.
Seminars in Immunology (2025) Vol. 78, pp. 101946-101946
Open Access
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress
Torleif Tollefsrud Gjølberg, Simone Mester, Gaia Calamera, et al.
BioDrugs (2025)
Open Access
Torleif Tollefsrud Gjølberg, Simone Mester, Gaia Calamera, et al.
BioDrugs (2025)
Open Access
IgG Fab Glycans Hinder FcRn-Mediated Placental Transport
Mikhail Volkov, Maximilian Brinkhaus, Karin A. van Schie, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 2, pp. 158-167
Open Access | Times Cited: 12
Mikhail Volkov, Maximilian Brinkhaus, Karin A. van Schie, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 2, pp. 158-167
Open Access | Times Cited: 12
Bullous pemphigoid induced by IgG targeting type XVII collagen non‐NC16A /NC15A extracellular domains is driven by Fc gamma receptor‐ and complement‐mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade
Manuela Pigors, Sabrina Patzelt, Niklas Reichhelm, et al.
The Journal of Pathology (2023) Vol. 262, Iss. 2, pp. 161-174
Open Access | Times Cited: 11
Manuela Pigors, Sabrina Patzelt, Niklas Reichhelm, et al.
The Journal of Pathology (2023) Vol. 262, Iss. 2, pp. 161-174
Open Access | Times Cited: 11
Multidimensional LC-MS with 1D multi-method option and parallel middle-up and bottom-up MS acquisition for in-depth characterization of antibodies
Liesa Verscheure, Shauni Detremmerie, Hilde Stals, et al.
Journal of Chromatography A (2024) Vol. 1726, pp. 464947-464947
Closed Access | Times Cited: 4
Liesa Verscheure, Shauni Detremmerie, Hilde Stals, et al.
Journal of Chromatography A (2024) Vol. 1726, pp. 464947-464947
Closed Access | Times Cited: 4
Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin
Guanglong Ma, Andrew R. Crowley, Liesbeth Heyndrickx, et al.
JCI Insight (2024) Vol. 9, Iss. 10
Open Access | Times Cited: 4
Guanglong Ma, Andrew R. Crowley, Liesbeth Heyndrickx, et al.
JCI Insight (2024) Vol. 9, Iss. 10
Open Access | Times Cited: 4
SynBioNanoDesign: pioneering targeted drug delivery with engineered nanomaterials
Qian Cai, Rui Guo, Dafu Chen, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Qian Cai, Rui Guo, Dafu Chen, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Engineering FcRn binding kinetics dramatically extends antibody serum half-life and enhances therapeutic potential
Sanghwan Ko, Migyeong Jo, Munsu Kyung, et al.
Journal of Biological Engineering (2025) Vol. 19, Iss. 1
Open Access
Sanghwan Ko, Migyeong Jo, Munsu Kyung, et al.
Journal of Biological Engineering (2025) Vol. 19, Iss. 1
Open Access
Evidence for the Role of a Second Fc-Binding Receptor in Placental IgG Transfer in Nonhuman Primates
Yvonne J. Rosenberg, Tracy Ordonez, Urjeet S. Khanwalkar, et al.
mBio (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 9
Yvonne J. Rosenberg, Tracy Ordonez, Urjeet S. Khanwalkar, et al.
mBio (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 9
Biochemical properties of sheep colostrum and its potential benefits for lamb survival: a review
Umar Farooq, Sohail Ahmed, Guiqiong Liu, et al.
Animal Biotechnology (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 3
Umar Farooq, Sohail Ahmed, Guiqiong Liu, et al.
Animal Biotechnology (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 3
Cellular neonatal Fc receptor recycling efficiencies can differentiate target-independent clearance mechanisms of monoclonal antibodies
Mark A. Bryniarski, Md Tariqul Haque Tuhin, Timothy M. Acker, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 9, pp. 2879-2894
Open Access | Times Cited: 2
Mark A. Bryniarski, Md Tariqul Haque Tuhin, Timothy M. Acker, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 9, pp. 2879-2894
Open Access | Times Cited: 2
Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study
Peter C. Taylor, Georg Schett, T. Huizinga, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e004278-e004278
Open Access | Times Cited: 2
Peter C. Taylor, Georg Schett, T. Huizinga, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e004278-e004278
Open Access | Times Cited: 2
In silico evaluation of the role of Fab glycosylation in cetuximab antibody dynamics
Simona Saporiti, Davide Bianchi, Omar Ben Mariem, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Simona Saporiti, Davide Bianchi, Omar Ben Mariem, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndrome
Roeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 765
Closed Access | Times Cited: 2
Roeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 765
Closed Access | Times Cited: 2
Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling
Tulika Tulika, Fulgencio Ruso‐Julve, Shirin Ahmadi, et al.
Structure (2024) Vol. 32, Iss. 9, pp. 1404-1418.e7
Open Access | Times Cited: 1
Tulika Tulika, Fulgencio Ruso‐Julve, Shirin Ahmadi, et al.
Structure (2024) Vol. 32, Iss. 9, pp. 1404-1418.e7
Open Access | Times Cited: 1
Selective IgG binding to the LPS glycolipid core found in bovine colostrum, or milk, during Escherichia coli mastitis influences endotoxin function
Suzanne M. Hurst, David A. L. Flossdorf, Raveen Koralagamage Don, et al.
Innate Immunity (2024) Vol. 30, Iss. 5, pp. 96-118
Open Access
Suzanne M. Hurst, David A. L. Flossdorf, Raveen Koralagamage Don, et al.
Innate Immunity (2024) Vol. 30, Iss. 5, pp. 96-118
Open Access
Antigen specificity shapes antibody functions in tuberculosis.
Joshua Miles, Pei Lu, Shuangyi Bai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Joshua Miles, Pei Lu, Shuangyi Bai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Binding to the neonatal Fc receptor enhances the pathogenicity of anti-desmoglein-3 antibodies in keratinocytes
Anna Zakrzewicz, Katrien Vanderheyden, Yad Galaly, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Anna Zakrzewicz, Katrien Vanderheyden, Yad Galaly, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access